Receptor protein tyrosine phosphatases regulate retinal ganglion cell axon outgrowth in the developing Xenopus visual

K G Johnson1, I W McKinnell, A W Stoker

  • 1Department of Anatomy, University of Cambridge, Downing Street, Cambridge CB2 3DY, United Kingdom. karl_johnson@hms.harvard.edu

Journal of Neurobiology
|October 13, 2001
PubMed

Insights

Receptor protein tyrosine phosphatases (RPTPs) regulate retinal axon outgrowth. This study shows dominant-negative RPTP mutants inhibit axon growth in vivo, with PTP-delta significantly impacting outgrowth.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Cell Biology

Background:

  • Receptor protein tyrosine phosphatases (RPTPs) are crucial for axon development.
  • Specific RPTPs (CRYP-alpha, PTP-delta, LAR) are present in the developing Xenopus retina.
  • Their precise roles in retinal ganglion cell (RGC) axon development are not fully understood.

Purpose of the Study:

  • To investigate the function of RPTPs in Xenopus retinal axon development.
  • To determine the effects of dominant-negative RPTP mutants on RGC axon outgrowth and guidance.

Main Methods:

  • Expression of dominant-negative RPTP mutants (CS-CRYP-alpha, CS-PTP-delta, CS-LAR) in retinal cells.
  • Assessment of RGC axon guidance and outgrowth in vivo and in vitro.
  • Analysis of effects on retinal cell fate determination.

Main Results:

  • No significant effect on retinal cell fate or gross RGC axon guidance to the tectum.
  • In vivo, dominant-negative RPTPs (all three or CS-PTP-delta alone) inhibited RGC axon outgrowth.
  • In vitro, CS-CRYP-alpha enhanced neurite outgrowth, while CS-PTP-delta inhibited it in a substrate-dependent manner.

Conclusions:

  • RPTPs play a significant role in regulating the rate of retinal axon outgrowth.
  • This study provides the first in vivo evidence for RPTPs controlling retinal axon outgrowth, particularly highlighting PTP-delta's inhibitory role.

Related Concept Videos

The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: